Anxiety Disorder Treatment Market Regional Analysis, Key Players Profiles and Future Prospects 2027

Various factors are adding to the global anxiety disorder treatment market share. These factors, as per the new MRFR report, include the launch of technologically advanced therapies, change in lifestyle, increasing geriatric population having anxiety disorders, availability of favorable reimbursement policies especially in developed countries for therapies medication, need for effective symptoms of anxiety, and rising prevalence of anxiety disorders such as agoraphobia, generalized anxiety disorder, social anxiety disorder, and others. Additional factors adding market growth include high success rates, burgeoning demand for antidepressants for minimum side effects, and increasing consumers’ awareness about various anxiety disorder treatments.

The global anxiety disorder treatment market was valued USD 11.54 million in 2018 and is predicted to grow at a 5.4% CAGR between forecast period, reveals the new Market Research Future (MRFR) report. Anxiety disorder, simply put, is a mental health disorder which is characterized by feelings of fear, anxiety, or worries which are strong enough to interfere with the daily activities of a person.

On the contrary, the availability of generic biosimilars, rising rate of drug withdrawals, and patent expiration of branded drugs are factors that may limit the global anxiety disorder treatment market growth over the forecast period.

The report offers an all-inclusive analysis of the global psychological treatment for anxiety. The market has been segmented by end user, drug class, and region. The report throws light on the market share, trends, and size of the anxiety disorder treatment market.

Key Players

Eminent players profiled in the global anxiety disorder treatment market report include Bristol-Myers Squibb Company (US), Lundbeck A/S (Denmark), Johnson Johnson (US), GlaxoSmithKline PLC (UK), Pfizer, Inc. (US), Merck Co., Inc. (US), Sanofi-Aventis (France), AstraZeneca PLC (UK), Forest Laboratories, Inc. (US), and Eli Lilly and Company (US).

Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the global anxiety disorder treatment market based on end user and drug class.

  • By Drug Classes listed in the report are SNRIs (serotonin-norepinephrine reuptake inhibitors), SSRIs (selective serotonin reuptake inhibitors), pregabalin, TCAs (tricyclic antidepressants), benzodiazepines, buspirone, and more.
  • By End-users in the anxiety disorder treatment industry include asylums, mental healthcare centers, hospitals, and others. The anxiety disorders treatment market size by application is primarily led by the hospital segment, out of all the end-users. This is the result of the expanding patient pool suffering from social anxiety disorder, along with the rising financial status of several healthcare settings. The soaring number of hospitals across different countries in the world, accompanied by the surge in government efforts for improving the healthcare industry also encourages segmental growth.

Regional Analysis

Based on the region, the global anxiety disorder treatment market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East Africa. Among these, the Americas will dominate the market over the forecast period for the rising cases of anxiety disorder. The US is the key contributor in the region for the stressful environments and sedentary lifestyles that has increased anxiety disorder cases.

The global anxiety disorder treatment market in Europe is predicted to hold the second-largest share over the forecast period for the rising public awareness regarding anxiety disorders that has boosted the need for effective anxiety disorder treatments.

The global anxiety disorder treatment market in the APAC region is predicted to grow at a fast pace over the forecast period. Factors propelling the anxiety disorder treatment market growth in the region include the rising prevalence of anxiety disorders like generalized anxiety disorder. The rising cases of psychological diseases are boosting the need for effective therapy for treating anxiety disorders.

The global anxiety disorder treatment market in the MEA is predicted to have the smallest share during the forecast period due to lack of awareness regarding anxiety disorder treatment and limited healthcare infrastructure.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

Comments are closed